Applications of the Hematopoietic CFU Assay in Toxicity Testing

Therapeutic drug development is a long and expensive process. Screening for potential toxicity as early as possible may help you select the relevant lead candidates to advance in the drug development process. In this webinar, you’ll learn from hematopoietic expert Dr. Jackie Damen about the importance of hematotoxicity testing in drug development and how hematopoietic colony forming unit (CFU) assays can be applied in toxicity testing to assist in the successful screening of your small molecule compounds and biologics. In her role as Senior Scientific Advisor, Hematopoiesis, as well as her past experience as Director of Contract Assay Services at STEMCELL Technologies, Dr. Damen has conducted hundreds of customized studies involving the CFU assay to provide numerous pharmaceutical and biotechnology clients with solutions to their drug development questions. Email for more information.
Publish Date: January 17, 2020

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.